Hydroxychloroquine Reduces COVID-19 Mortality, Study Finds

 People who took hydroxychloroquine in combination with another drug while hospitalized with COVID-19 were less likely to die than those who didn't, according to a new study.

Hydroxychloroquine, which is widely used against malaria and arthritis, was given to hundreds of patients hospitalized with COVID-19 in Belgium.

How Quercetin Works Like Hydroxychloroquine to Stop Viruses Play Video "Our study suggests that, despite the controversy surrounding its use, treatment with hydroxychloroquine and azithromycin remains a viable option," Dr. Gert Meeus, a nephrologist with AZ Groeninge Hospital, and other researchers wrote.

The research adds to a mixed dataset on hydroxychloroquine against COVID-19.

Others have found little or no evidence that hydroxychloroquine affects COVID-19, including a U.S.-government funded study across 34 hospitals.

Multiple studies on hydroxychloroquine and COVID-19 have been retracted.

Dosage Issue? Hydroxychloroquine proponents say that the amount of the drug, and when it's given, is key to properly studying how it affects COVID-19.

https://www.theepochtimes.com/health/hydroxychloroquine-reduces-covid-19-mortality-study-finds-5506543?utm_source=partner&utm_campaign=ZeroHedge&src_src=partner&src_cmp=ZeroHedge